|
FY2022
12 months to Dec 31, 2022
|
FY2021
11 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Expensed offering costs | ||
| Change in fair value of promissory note - related party | ||
| Interest income on Trust Account | ||
| Loss on sale of private placement warrants | ||
| Change in fair value of warrant liabilities | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Accounts payable and accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Cash deposited in Trust Account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from promissory note - related party | ||
| Proceeds from initial public offering, net of underwriter's discount paid | ||
| Proceeds from sale of private placement warrants | ||
| Offering costs paid | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash - Beginning of Period | ||
| Cash - End of Period | ||
| Supplemental disclosure of noncash investing and financing activities: | ||
| Remeasurement of Class A ordinary shares subject to possible redemption | ||
| Deferred underwriting fee payable | ||
| Forgiveness of deferred underwriting fee payable | ||
| Forfeiture of Class B ordinary shares |
Loading...
